Moleculin Biotech, Inc.
MBRX
$2.34
-$0.10-4.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 107.53% | -28.73% | -30.32% | -54.14% | -81.83% |
| Total Receivables | -65.00% | -- | -44.44% | -- | -79.80% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.43% | -63.24% | -54.42% | -86.26% | -72.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -16.01% | -- | -10.07% | -- | -39.27% |
| Total Current Assets | 86.48% | -32.06% | -33.90% | -50.73% | -80.23% |
|
|
|||||
| Total Current Assets | 86.48% | -32.06% | -33.90% | -50.73% | -80.23% |
| Net Property, Plant & Equipment | -32.76% | -34.38% | -32.61% | -29.05% | -26.76% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 30.73% | -13.00% | -15.57% | -31.88% | -55.71% |
|
|
|||||
| Total Accounts Payable | 72.81% | -17.02% | 31.34% | 28.61% | -18.73% |
| Total Accrued Expenses | 0.00% | 17.32% | 45.09% | 27.26% | -23.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.17% | 13.79% | 14.29% | 13.76% | 20.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.90% | 1.59% | 37.71% | 27.51% | -21.36% |
|
|
|||||
| Total Current Liabilities | 27.90% | 1.59% | 37.71% | 27.51% | -21.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -37.99% | -33.85% | -30.48% | -27.56% | -24.47% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 316.16% | 1,106.16% | 304.38% | -- |
| Total Liabilities | 24.54% | 197.03% | 265.41% | 126.52% | -52.92% |
|
|
|||||
| Common Stock & APIC | 20.31% | 22.47% | 1.08% | 1.08% | 16.49% |
| Retained Earnings | -19.46% | -46.26% | -18.84% | -17.01% | -31.03% |
| Treasury Stock & Other | 124.39% | -1,200.00% | -280.00% | -111.11% | -355.56% |
| Total Common Equity | 33.89% | -459.94% | -140.47% | -99.81% | -57.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.89% | -459.94% | -140.47% | -99.81% | -57.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.89% | -459.94% | -140.47% | -99.81% | -57.01% |
|
|
|||||